NEW YORK, May 21 (GenomeWeb News) - The National Institute of Allergy and Infectious Diseases announced on Monday that it plans to provide $125 million in funding in FY 2005 for the construction of five to eight Regional Biocontainment Laboratories.
Winning institutions must provide matching funds of at least 25 percent of the total cost of the project. The NIAID will provide at least $15-$25 million in costs.
The RBLs will support NIAID funded research in biodefense and emerging infectious diseases and will be made available to assist in the case of a national emergency. They will supplement two national biocontainment laboratories and nine other RBLs funded last fall, as well as eight Regional Centers of Excellence in Biodefense and Emerging Infectious diseases. The RCEs will all fund research projects in genomics or proteomics as part of their mandates.
The NIAID is not yet soliciting applications for the project. The document announcing the intent to issue a request for applications can be found here.